Drug intelligence / Profile preview

Purified Vero cell rabies vaccine

Development stage
Approved
Lead developer
Sanofi Pasteur
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular, Intradermal
01

Overview

Purified Vero Cell Rabies Vaccine is an inactivated viral vaccine used for the prevention of rabies before and after exposure to the virus. The vaccine is produced by growing the Pitman-Moore strain of the rabies virus in Vero cells (a type of kidney epithelial cell line from African green monkeys), followed by purification and inactivation so that it cannot cause disease but can stimulate a protective immune response. Upon administration, it induces production of neutralizing antibodies against the rabies virus, providing immunity to individuals at risk or exposed to potential infection. It is indicated for pre-exposure prophylaxis (for travelers or high-risk occupations) and post-exposure prophylaxis following animal bites or scratches[1][2][3][5]. Multiple brands exist globally; notable examples include Verorab (Sanofi Pasteur), Rabivax-S (developed on Vero ATCC CCL81 cells using Pitman Moore PM3218 strain), and SPEEDA PVRV (Liaoning Chengda Biology Co.)[2][6][8].

Brand names
VerorabRabivax-SSPEEDA PVRV
Other names
purified vero cell rabies vaccineinactivated rabies virus vaccine (vero cell)PVRV-NG
02

Targets

RABV-G (Rabies virus glycoprotein)

Beyond the preview

Go deeper on Purified Vero cell rabies vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purified Vero cell rabies vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call